Pricing Log in Create free account

Cellyan Biotechnology Co., Ltd (HKPD) vs 111, Inc. Sponsored ADR (YI)

Cellyan Biotechnology Co., Ltd and 111, Inc. Sponsored ADR are both Medical Distribution companies. 111, Inc. Sponsored ADR is the larger, with a market value of $15.5M against $3.4M — 4.6× the size. Across the 8 metrics below, Cellyan Biotechnology Co., Ltd leads on 4 and 111, Inc. Sponsored ADR on 4.

Valuation

Metric HKPD YI Medical Distribution median
P/E — n/m —
P/S — 0.02 0.27
P/B n/m n/m —
Price to free cash flow n/m n/m —
EV/EBITDA n/m n/m 17.33
EV/Sales n/m 0.00 0.86
Earnings yield — (47.50%) (13.85%)
Free cash flow yield 0.00% (79.83%) (6.11%)

Profitability

Metric HKPD YI Medical Distribution median
Gross margin — 5.74% 5.74%
Operating margin — (0.20%) 0.00%
Net margin — (0.75%) (11.41%)
Free cash flow margin 0.00% (0.71%) (0.36%)
Return on equity 0.00% 12.26% 0.00%
Return on assets 0.00% (3.89%) (1.95%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HKPD YI Medical Distribution median
Revenue growth (TTM) — (16.19%) 6.15%
EPS growth (last fiscal year) (2,521.89%) 3.14% 5.18%
Revenue growth, 5-year CAGR — 7.39% 8.18%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HKPD YI Medical Distribution median
Debt to equity 0.10 (0.34) (0.66)
Current ratio 3.86 1.08 0.99
Net debt to EBITDA (0.79) (44.78) (0.10)

Dividend

Metric HKPD YI Medical Distribution median
Dividend yield — — —
Payout ratio — — —

Size

Metric HKPD YI Medical Distribution median
Market cap 3.35m 15.47m 97.81m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack